Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
191.57 USD | -0.23% |
|
-3.46% | +10.07% |
Feb. 06 | Northcoast Research Adjusts CDW's Price Target to $240 From $250 | MT |
Feb. 06 | Morgan Stanley Adjusts CDW's Price Target to $201 From $193 | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 18.03B | 18.47B | 20.82B | 23.75B | 21.38B | |||||
Total Revenues | 18.03B | 18.47B | 20.82B | 23.75B | 21.38B | |||||
Cost of Goods Sold, Total | 14.99B | 15.26B | 17.25B | 19.06B | 16.72B | |||||
Gross Profit | 3.04B | 3.21B | 3.57B | 4.69B | 4.65B | |||||
Selling General & Admin Expenses, Total | 1.91B | 2.02B | 2.1B | 2.9B | 2.89B | |||||
Other Operating Expenses, Total | 1.91B | 2.02B | 2.1B | 2.9B | 2.89B | |||||
Operating Income | 1.13B | 1.19B | 1.47B | 1.78B | 1.76B | |||||
Interest Expense, Total | -159M | -155M | -151M | -236M | -227M | |||||
Net Interest Expenses | -159M | -155M | -151M | -236M | -227M | |||||
Income (Loss) On Equity Invest. | - | - | - | - | - | |||||
Other Non Operating Income (Expenses) | -24.5M | -22M | -300K | -10.1M | -4.1M | |||||
EBT, Excl. Unusual Items | 950M | 1.01B | 1.32B | 1.54B | 1.53B | |||||
Restructuring Charges | - | -8.5M | - | - | -47.7M | |||||
Merger & Related Restructuring Charges | - | - | -54.3M | -48.3M | -30M | |||||
Gain (Loss) On Sale Of Investments | - | - | 36M | - | - | |||||
Other Unusual Items | - | - | -6M | -1.6M | - | |||||
EBT, Incl. Unusual Items | 950M | 1B | 1.3B | 1.49B | 1.45B | |||||
Income Tax Expense | 213M | 214M | 309M | 373M | 346M | |||||
Earnings From Continuing Operations | 737M | 788M | 989M | 1.11B | 1.1B | |||||
Net Income to Company | 737M | 788M | 989M | 1.11B | 1.1B | |||||
Net Income - (IS) | 737M | 788M | 989M | 1.11B | 1.1B | |||||
Net Income to Common Incl Extra Items | 737M | 788M | 989M | 1.11B | 1.1B | |||||
Net Income to Common Excl. Extra Items | 737M | 788M | 989M | 1.11B | 1.1B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 5.08 | 5.53 | 7.14 | 8.24 | 8.2 | |||||
Basic EPS - Continuing Operations | 5.08 | 5.53 | 7.14 | 8.24 | 8.2 | |||||
Basic Weighted Average Shares Outstanding | 145M | 143M | 138M | 135M | 135M | |||||
Net EPS - Diluted | 4.99 | 5.45 | 7.04 | 8.13 | 8.1 | |||||
Diluted EPS - Continuing Operations | 4.99 | 5.45 | 7.04 | 8.13 | 8.1 | |||||
Diluted Weighted Average Shares Outstanding | 148M | 145M | 140M | 137M | 136M | |||||
Normalized Basic EPS | 4.09 | 4.43 | 5.97 | 7.11 | 7.09 | |||||
Normalized Diluted EPS | 4.02 | 4.36 | 5.88 | 7.02 | 7.01 | |||||
Dividend Per Share | 1.26 | 1.54 | 1.7 | 2.09 | 2.39 | |||||
Payout Ratio | 24.89 | 27.85 | 23.75 | 25.36 | 29.11 | |||||
American Depositary Receipts Ratio (ADR) | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |||||
Supplemental Items | ||||||||||
EBITDA | 1.4B | 1.61B | 1.66B | 2.07B | 2.03B | |||||
EBITA | 1.35B | 1.4B | 1.62B | 2.02B | 1.98B | |||||
EBIT | 1.13B | 1.19B | 1.47B | 1.78B | 1.76B | |||||
EBITDAR | 1.49B | 1.67B | 1.71B | 2.14B | 2.09B | |||||
Effective Tax Rate - (Ratio) | 22.42 | 21.33 | 23.82 | 25.09 | 23.85 | |||||
Current Domestic Taxes | 281M | 216M | 288M | 358M | 337M | |||||
Current Foreign Taxes | 20M | 18.3M | 27.4M | 33.9M | 41.6M | |||||
Total Current Taxes | 301M | 234M | 316M | 392M | 379M | |||||
Deferred Domestic Taxes | -83M | -18.8M | -8.7M | -15M | -29.3M | |||||
Deferred Foreign Taxes | -4.9M | -1.4M | 2M | -3.2M | -3.4M | |||||
Total Deferred Taxes | -87.9M | -20.2M | -6.7M | -18.2M | -32.7M | |||||
Normalized Net Income | 594M | 632M | 826M | 961M | 955M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 193M | 191M | 199M | 211M | 215M | |||||
Selling and Marketing Expenses | 193M | 191M | 199M | 211M | 215M | |||||
Net Rental Expense, Total | 93.3M | 53M | 50M | 62M | 62M | |||||
Imputed Operating Lease Interest Expense | 31.53M | 15.35M | 9.92M | 16.5M | 17.39M | |||||
Imputed Operating Lease Depreciation | 61.77M | 37.65M | 40.08M | 45.5M | 44.61M | |||||
Stock-Based Comp., SG&A Exp. (Total) | 48.5M | 42.5M | 72.6M | 91.1M | 93.7M | |||||
Total Stock-Based Compensation | 48.5M | 42.5M | 72.6M | 91.1M | 93.7M |